EUVIMEDEUVIMED entdecken
Multizentrische Studie

PET/CT-based quantification of intratumoral heterogeneity for predicting pathological complete response in breast cancer patients treated with neoadjuvant chemotherapy: A multicentre study

Jiwen Zhang, Xin Yu, Xiaofen Li, Zhuokai Sun, Qinghua Meng, Ziyin Li, Shiping Luo, Yushuai Yu, Qing Wang, Ning Mao, Daojia Liu, Chuangui Song iD

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-026-07787-5 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Jiwen Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou, 350…. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Neoadjuvant Therapy, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, High-level Talent Introduction Project of Fujian Cancer Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To develop a quantitative measure of intratumoral heterogeneity (ITH) from pretreatment 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) images and to evaluate its potential for predicting pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in patients with breast cancer (BC). MATERIALS AND METHODS: This retrospective study included patients with BC who underwent NAC at four hospitals between 2013 and 2025. Tumour regions on pretreatment 18F-FDG PET/CT images were clustered to extract intratumoral ecological diversity features, while radiomic features were extracted from the entire tumour. Output probabilities from imaging-based extreme gradient boosting (XGBoost) models were used to generate an ITH index and a radiomics score, respectively. Logistic regression analysis was performed to identify variables associated with pCR. Significant variables, including clinicopathologic characteristics, radiomics score, and ITH index, were integrated into a combined predictive model (ICR-COME). Model performance and clinical utility were evaluated using receiver operating characteristic, calibration curve, and decision curve analyses (DCA). Survival differences between predicted pCR and non-pCR groups were assessed using Kaplan–Meier analysis. RNA sequencing data from 12 patients were analysed to further explore the biological basis of ICR-COME. RESULTS: The study included 323 women (median age, 51 years ± 10[SD]). For predicting pCR in BC patients, ICR-COME achieved the area under the receiver operating characteristic curve (AUC) values of 0.95 in the training cohort and 0.87 and 0.88 in external test cohorts B and C, respectively, which were significantly superior to those of the clinicopath model and the conventional radiomics model using 18F-FDG PET/CT (all P < 0.05, DeLong test). Calibration curve and DCA indicated that ICR-COME achieved satisfactory concordance and provided the greatest clinical net benefit. Patients in all three cohorts predicted as non-pCR exhibited poorer prognosis (P < 0.05, log-rank test). Furthermore, RNA sequencing and multiplex immunofluorescence analyses revealed that high ICR-COME scores were associated with increased immune cell infiltration and enhanced activation of immune-related pathways. CONCLUSIONS: ICR-COME, which integrates the ITH index, the radiomics score, and clinicopathologic variables, demonstrated strong predictive performance for pCR to NAC and prognosis in BC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyNeoadjuvant TherapyBreast NeoplasmsHumansPathologic Complete ResponseFemaleRetrospective StudiesMiddle AgedRadiomicsFluorodeoxyglucose F18Adult

Stichwörter der Autor:innen

18F-FDG PET/CTBreast cancerDisease-free survivalIntratumoral heterogeneityNeoadjuvant chemotherapyRNA sequencing analysisRadiomics

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou, 350014, Fujian, China.
  • Cardiff China Medical Research Collaborative (CCMRC), Division of Cancer and Genetics (DCG), Cardiff University School of Medicine, Cardiff, Wales, CF14 4XN, UK.
  • School of Computer Science and Technology, Shandong Technology and Business University, Yantai, 264000, Shandong, China.
  • Department of Radiology, Yantai Yuhuangding Hospital, Qingdao University, No.20 Yuhuangding East Road, Yantai, 264000, Shandong, P. R. China.
  • Department of Radiology, Yantai Yuhuangding Hospital, Qingdao University, No.20 Yuhuangding East Road, Yantai, 264000, Shandong, P. R. China. maoning@pku.edu.cn.
  • Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital (Fujian Branch of Fudan University Shanghai Cancer Center), Fuzhou, 350014, Fujian, China. ldj0701@163.com.

ORCID-Profile: Chuangui Song

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province
  • High-level Talent Introduction Project of Fujian Cancer Hospital

Zitieren

APA

Zhang, J., Yu, X., Li, X., Sun, Z., Meng, Q., Li, Z., Luo, S., Yu, Y., Wang, Q., Mao, N., Liu, D., & Song, C. (2026). PET/CT-based quantification of intratumoral heterogeneity for predicting pathological complete response in breast cancer patients treated with neoadjuvant chemotherapy: A multicentre study. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-07787-5

Vancouver

Zhang J, Yu X, Li X, Sun Z, Meng Q, Li Z, et al. PET/CT-based quantification of intratumoral heterogeneity for predicting pathological complete response in breast cancer patients treated with neoadjuvant chemotherapy: A multicentre study. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-07787-5

BibTeX
@article{Zhang2026,
  author = {Zhang, Jiwen and Yu, Xin and Li, Xiaofen and Sun, Zhuokai and Meng, Qinghua and Li, Ziyin and Luo, Shiping and Yu, Yushuai and Wang, Qing and Mao, Ning and Liu, Daojia and Song, Chuangui},
  title = {PET/CT-based quantification of intratumoral heterogeneity for predicting pathological complete response in breast cancer patients treated with neoadjuvant chemotherapy: A multicentre study},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-026-07787-5}
}
Kostenlos starten →